RBC Capital assumed coverage of HealthEquity (HQY) with an Outperform rating and price target of $112, up from $105. The company is well positioned in the growing health savings account market, with its leading market share continuing to increase, the analyst tells investors in a research note. The firm says that through both its shift to higher yields on cash balances and leveraging technology to drive down the cost of servicing accounts, HealthEquity should post continued high-single-digit revenue growth and expanding margins.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- Positive Legislative Changes Boost Healthequity’s Growth Prospects: A Buy Rating Justification
- Paul Black Resigns from HealthEquity Board
- Buy Recommendation for Healthequity: Favorable Rate Environment and Stable Revenue Projections
- HealthEquity price target lowered to $100 from $110 at KeyBanc
- HealthEquity management to meet virtually with Barrington